Monsanto appeals damning Roundup cancer verdict

San Francisco: Monsanto on Tuesday said it is asking an appeals court to toss out a damning verdict in a landmark Roundup weed-killer cancer trial and grant it another try.

“By its appeal from the judgment and amended judgment, Monsanto also seeks appellate review of the trial court’s order denying Monsanto’s motion for new trial,” an attorney for the agrochemical colossus said in a filed notice-of-appeal.

The notice is the first step of the appeal process.

A cancer-stricken groundskeeper last month accepted a slashed award in the trial, which focused on weed-killer Roundup and a professional version of the herbicide called Ranger Pro.

Judge Suzanne Bolanos, who presided over the case in California state court, denied a Monsanto’s request for a new trial but cut the $289 million damages award to $78 million to comply with the law regarding how punitive damages awards must be calculated.

Bolanos denied a request by Monsanto to toss out the jury’s overall verdict against the company.

Jurors in August unanimously found that Monsanto acted with “malice” and that its weed killers Roundup and Ranger Pro contributed “substantially” to Dewayne “Lee” Johnson’s terminal illness.

The jury ordered Monsanto to pay $250 million in punitive damages along with compensatory damages and other costs, bringing the total figure to nearly $290 million.

Johnson, a California groundskeeper diagnosed in 2014 with non-Hodgkin’s lymphoma — a cancer that affects white blood cells — says he repeatedly used Ranger Pro while working at a school in Benicia, California.

Monsanto-parent Bayer at the time called the reduced punitive damage award a “step in the right direction” but held firm in its argument that the jury’s decision was not supported by evidence at trial.

– More to come? – Johnson’s lawsuit built on 2015 findings by the International Agency for Research on Cancer, part of the UN World Health Organization, which classified Roundup’s main ingredient glyphosate as a probable carcinogen, causing the state of California to follow suit.

Monsanto has defended the weed killer, arguing that it has a history of safe use that dates back more than 40 years.

The lawsuit is the first to accuse the product of causing cancer, but observers say a Monsanto defeat likely opens the door to thousands of other claims against the company, which was recently acquired by Germany’s Bayer.

Roundup is Monsanto’s leading product.

Founded in 1901 in St Louis, Missouri, Monsanto began producing agrochemicals in the 1940s. It was acquired by Bayer for more than $62 billion in June.

Monsanto launched Roundup in 1976 and soon thereafter began genetically modifying plants, making some resistant to Roundup.

  • Related Posts

    Health ministry strengthens allied and healthcare education and professional standards

    The Union ministry of health and family welfare is strengthening the education, training and professional standards of allied and healthcare professions to build a skilled, competent and future-ready healthcare workforce…

    Siddhanta Super Speciality Hospital’s registration, licence cancelled in Bhopal: CMHO inspection finds 19 serious lapses from emergency to ICU; dialysis rules violated

    The registration and licence of Siddhanta Super Speciality Hospital in Shivaji Nagar, Bhopal, have been cancelled after a CMHO inspection found 19 serious lapses. The violations ranged from a lack…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Health ministry strengthens allied and healthcare education and professional standards

    Health ministry strengthens allied and healthcare education and professional standards

    Siddhanta Super Speciality Hospital’s registration, licence cancelled in Bhopal: CMHO inspection finds 19 serious lapses from emergency to ICU; dialysis rules violated

    Siddhanta Super Speciality Hospital’s registration, licence cancelled in Bhopal: CMHO inspection finds 19 serious lapses from emergency to ICU; dialysis rules violated

    Chemist selling narcotics held, medical store sealed

    Chemist selling narcotics held, medical store sealed

    Systech launches TraceIQ, an intelligent and easy-to-use platform to transform pharma traceability from compliance to operational intelligence

    Systech launches TraceIQ, an intelligent and easy-to-use platform to transform pharma traceability from compliance to operational intelligence

    Amway India launches range of new products under Nutrilite Ayurveda

    Amway India launches range of new products under Nutrilite Ayurveda

    Yashoda Medicity’s Medical Tourism Footprint widens with Republic of Kazakhstan on Board

    Yashoda Medicity’s Medical Tourism Footprint widens with Republic of Kazakhstan on Board